Skip to content

Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant

Randomized Clinical Study Comparing the Effectiveness of the Stanford Letter to the Traditional Advance Directive in Bone Marrow Transplant Recipients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03028961
Acronym
BMTSLPRCT
Enrollment
126
Registered
2017-01-23
Start date
2017-03-03
Completion date
2021-07-27
Last updated
2022-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Directives, Bone Marrow Transplant

Brief summary

The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive. Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.

Detailed description

PRIMARY OBJECTIVES I. To compare advance care planning (ACP) completion rate amongst bone marrow transplant (BMT) recipients receiving the Stanford Letter versus the traditional advance directive (AD) through a prospective, pilot randomized controlled trial (RCT). SECONDARY OBJECTIVES: I. To evaluate differences in patient preference for choice to prolong life following completion of the ACP tool in each group. II. To assess uncertainty with decision making regarding end of life care following completion of the ACP tool in each group. III. To explore patient understanding of and satisfaction with the ACP tool in each group. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I (INTERVENTION): Patients listen to a dialogue on the purpose of ACP. Patients receive a paper copy and online web link to the Stanford Letter and complete and return the form by the day of BMT. After completion of the Stanford Letter, patients undergo a semi-structured, research staff-led interview to evaluate personal perceptions of uncertainty with end-of-life decisions, understanding of the ACP form received, and satisfaction with the ACP form. GROUP II (CONTROL): Patients listen to a dialogue on the purpose of ACP. Patients receive a paper copy and online web link to the California (CA) Advance Health Care Directive Form and complete and return the form by the day of BMT. After completion of the CA Advance Health Care Directive Form, patients undergo interview as in Group I. After completion of study, patients are followed up periodically.

Interventions

OTHERStanford Letter

Receive and complete the Stanford Letter

OTHERInterview

Undergo semi-structured, research staff-led interview

OTHERQuestionnaire Administration

Ancillary studies

OTHERCA Advance Health Care Directive Form

Receive and complete the CA Advance Health Care Directive Form

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* All BMT patients at Stanford who are adults and give consent

Exclusion criteria

* Less than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
ACP completion rate defined as a completed Advance Directive tool (either Stanford Letter or standard CA AD) brought to Stanford University for upload into the medical recordUp to BMT day 0The chi-square (X\^2) test will be used to determine a significant difference in proportion of ACP tool completion and preferences for choice to prolong life between the two groups.

Secondary

MeasureTime frameDescription
Patient preferences for life sustaining measures measured via answers to the ACP questions related to use of cardiopulmonary resuscitation and use of mechanical intubationUp to BMT day 0The X\^2 test will be used to determine a significant difference in proportion of ACP tool completion and preferences for choice to prolong life between the two groups.
Uncertainty with decision making regarding end of life care measured related to the Decisional Conflict Scale (DCS) resultsUp to BMT day 0Will be measured using the DCS uncertainty sub-scale (score 0-15; higher score indicates greater uncertainty). Scores from each group will be compared by t-tests.
Understanding of the ACP tool measured using qualitative and quantitative data obtained through the semi-structured interview and DCSwithin 28 days of ACP completionWill be measured using the DCS effective decision-making sub-scale (score 0-15; higher scores indicate 6 less effective decision-making). Likert scores of understanding of the ACP from each group will be summarized and compared by t-tests.
Satisfaction with the ACP tool measured using qualitative and quantitative data obtained through the semi-structured interview and DCSwithin 28 days of ACP completionWill be measured using the DCS effective decision-making sub-scale (score 0-15; higher scores indicate 6 less effective decision-making). Scores from each group will be compared by t-tests. Likert scores of satisfaction with the ACP will be summarized and compared by group using t-tests.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026